Marco Merli

1.7k total citations
64 papers, 531 citations indexed

About

Marco Merli is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Marco Merli has authored 64 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 21 papers in Hepatology and 19 papers in Infectious Diseases. Recurrent topics in Marco Merli's work include Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (11 papers). Marco Merli is often cited by papers focused on Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (11 papers). Marco Merli collaborates with scholars based in Italy, United States and Germany. Marco Merli's co-authors include Caterina Uberti‐Foppa, Massimo Puoti, Adriano Lazzarin, Giulia Morsica, Hamid Hasson, Sabrina Bagaglio, N Violante, Isabella Quinti, L. Capocaccia and Emanuela Messina and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Marco Merli

56 papers receiving 516 citations

Peers

Marco Merli
Poonam Coshic India
Y.A.S. Sens Brazil
Dilek Yıldız Sevgi Türkiye
A.I. Saeed United States
Mohamed A. Hassan United States
Stephen T. Barclay United Kingdom
Jesús Sanz Spain
Shubhra Mishra India
Gecilmara Salviato Pileggi Brazil
Melina de Barros Pinheiro Brazil
Poonam Coshic India
Marco Merli
Citations per year, relative to Marco Merli Marco Merli (= 1×) peers Poonam Coshic

Countries citing papers authored by Marco Merli

Since Specialization
Citations

This map shows the geographic impact of Marco Merli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Merli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Merli more than expected).

Fields of papers citing papers by Marco Merli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Merli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Merli. The network helps show where Marco Merli may publish in the future.

Co-authorship network of co-authors of Marco Merli

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Merli. A scholar is included among the top collaborators of Marco Merli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Merli. Marco Merli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Travi, Giovanna, Alessandra Bielli, Elisa Matarazzo, et al.. (2025). Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control. Microorganisms. 13(4). 822–822.
2.
Iavarone, Massimo, Massimo Puoti, Hamid Hasson, et al.. (2025). Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. Liver International. 45(12). e70437–e70437.
3.
Merli, Mauro, et al.. (2025). A Personalized 4D Workflow for the Manufacturing of Functional and Removable Esthetic Devices: A Technical Report. Journal of Esthetic and Restorative Dentistry. 37(7). 1645–1654. 2 indexed citations
4.
Rossotti, Roberto, Chiara Baiguera, Elena Di Gennaro, et al.. (2025). Patterns and Correlates of Initiation of Long-Acting Injectable Cabotegravir for Preexposure Prophylaxis: A Case-Control Analysis. Sexually Transmitted Diseases. 53(3). 183–186.
5.
Ricci, Elena, Matteo Faltoni, Giordano Madeddu, et al.. (2024). Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections. Journal of Global Antimicrobial Resistance. 39. 4–4.
6.
7.
Travi, Giovanna, Marco Merli, Elisa Matarazzo, et al.. (2024). Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak. Antibiotics. 13(8). 770–770. 2 indexed citations
8.
Piazza, Aurora, Vittoria Mattioni Marchetti, Alessandra Bielli, et al.. (2024). A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy. Journal of Microbiology Immunology and Infection. 57(3). 457–469. 2 indexed citations
9.
Scutari, Rossana, Silvia Renica, Valeria Cento, et al.. (2023). Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantification. PLoS ONE. 18(9). e0291120–e0291120. 1 indexed citations
10.
Merli, Marco, Federico D’Amico, Giovanna Travi, & Massimo Puoti. (2023). Current State of Antimicrobial Treatment of Lower Respiratory Tract Infections Due to Carbapenem-Resistant Acinetobacter baumannii. SHILAP Revista de lepidopterología. 3(2). 473–487. 2 indexed citations
11.
Morici, Nuccia, Gian Marco Podda, Simone Birocchi, et al.. (2021). Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial. European Journal of Clinical Investigation. 52(5). e13735–e13735. 31 indexed citations
12.
Rossotti, Roberto, Giovanna Travi, Nicola Ughi, et al.. (2020). Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. Journal of Infection. 81(4). e11–e17. 83 indexed citations
13.
Gianotti, Nicola, Andrea Poli, Silvia Nozza, et al.. (2017). Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients. BMC Infectious Diseases. 17(1). 723–723. 5 indexed citations
14.
Sagnelli, Caterina, Caterina Uberti‐Foppa, Hamid Hasson, et al.. (2017). Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. PLoS ONE. 12(7). e0181890–e0181890. 11 indexed citations
15.
Sagnelli, Caterina, Marco Merli, Caterina Uberti‐Foppa, et al.. (2016). Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. Clinical Microbiology and Infection. 22(4). 372–378. 13 indexed citations
16.
Merli, Marco, Laura Galli, Letizia Marinaro, et al.. (2016). Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis. Journal of Antimicrobial Chemotherapy. 72(3). dkw492–dkw492. 8 indexed citations
17.
Giannelli, V., M. Giusto, Giovanna Gentile, et al.. (2013). 158 RESPONSE PREDICTION IN CHRONIC HEPATITIS C AFTER LIVER TRANSPLANT BY ASSESSMENT ENT-1-RELATED SINGLE NUCLEOTIDE POLYMORPHISMS. Journal of Hepatology. 58. S71–S71. 1 indexed citations
18.
Merli, Marco & Alberto Palloni. (2006). The HIV/AIDS Epidemic, Kin Relations, Living Arrangements, and the African Elderly in South Africa. 41(2). 167–173. 13 indexed citations
19.
Catena, E, Filippo Milazzo, Roberto Paino, et al.. (2004). Echocardiographic approach in a new left ventricular assist device: impella recover 100. Journal of the American Society of Echocardiography. 17(5). 470–473. 16 indexed citations
20.
Oppizzi, Michele, et al.. (1992). Transoesophageal echocardiography (TEE) during cardiopulmonary resuscitation. Journal of Cardiothoracic and Vascular Anesthesia. 6(1). 1–1. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Poonam Coshic Breakdown of academic impact, for papers by Y.A.S. Sens Breakdown of academic impact, for papers by Dilek Yıldız Sevgi Breakdown of academic impact, for papers by A.I. Saeed Breakdown of academic impact, for papers by Mohamed A. Hassan Breakdown of academic impact, for papers by Stephen T. Barclay Breakdown of academic impact, for papers by Jesús Sanz Breakdown of academic impact, for papers by Shubhra Mishra Breakdown of academic impact, for papers by Gecilmara Salviato Pileggi Breakdown of academic impact, for papers by Melina de Barros Pinheiro
Rankless by CCL
2026